BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36473936)

  • 1. Mitochondrial PARP1 regulates NAD
    Lee JH; Hussain M; Kim EW; Cheng SJ; Leung AKL; Fakouri NB; Croteau DL; Bohr VA
    Exp Mol Med; 2022 Dec; 54(12):2135-2147. PubMed ID: 36473936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner.
    Herrmann GK; Russell WK; Garg NJ; Yin YW
    J Biol Chem; 2021; 296():100309. PubMed ID: 33482196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ribose-functionalized NAD
    Zhang XN; Cheng Q; Chen J; Lam AT; Lu Y; Dai Z; Pei H; Evdokimov NM; Louie SG; Zhang Y
    Nat Commun; 2019 Sep; 10(1):4196. PubMed ID: 31519936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.
    Jang HJ; Park E; Jung HJ; Kwon TH
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F69-F85. PubMed ID: 37855039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.
    Krüger A; Bürkle A; Hauser K; Mangerich A
    Nat Commun; 2020 May; 11(1):2174. PubMed ID: 32358582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing PARP1 Activity: Small Molecule Reactants and Attached Chains of Poly (ADP-Ribose).
    Rudolph J; Luger K
    Methods Mol Biol; 2023; 2609():61-73. PubMed ID: 36515829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms governing PARP expression, localization, and activity in cells.
    Sanderson DJ; Cohen MS
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Double-Edged Sword: The Two Faces of PARylation.
    Kang M; Park S; Park SH; Lee HG; Park JH
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase-1 inhibits mitochondrial respiration by suppressing PGC-1α activity in neurons.
    Lu P; Hogan-Cann AD; Kamboj A; Roy Chowdhury SK; Aghanoori MR; Fernyhough P; Anderson CM
    Neuropharmacology; 2019 Dec; 160():107755. PubMed ID: 31487495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
    Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage.
    Liu HY; Liu YY; Zhang YL; Ning Y; Zhang FL; Li DQ
    Cell Commun Signal; 2022 Aug; 20(1):127. PubMed ID: 35986334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
    Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J
    J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of mitochondrial SLC25A51 enhances PARP1-dependent DNA repair by increasing nuclear NAD+ levels.
    Güldenpfennig A; Hopp AK; Muskalla L; Manetsch P; Raith F; Hellweg L; Dördelmann C; Leslie Pedrioli DM; Johnsson K; Superti-Furga G; Hottiger MO
    Nucleic Acids Res; 2023 Sep; 51(17):9248-9265. PubMed ID: 37587695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial NUDIX hydrolases: A metabolic link between NAD catabolism, GTP and mitochondrial dynamics.
    Long A; Klimova N; Kristian T
    Neurochem Int; 2017 Oct; 109():193-201. PubMed ID: 28302504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
    Jain PG; Patel BD
    Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of PARP1, PARP2 and poly(ADP-ribosyl)ation to base excision repair in the nucleosomal context.
    Kutuzov MM; Belousova EA; Kurgina TA; Ukraintsev AA; Vasil'eva IA; Khodyreva SN; Lavrik OI
    Sci Rep; 2021 Mar; 11(1):4849. PubMed ID: 33649352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.